Cellectis (CLLS) Gross Margin Growth (3y) (2018 - 2023)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Gross Margin Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,216,509.61 Bn | 1,216,509.61 Bn | - | - |
| 2 | Alterity Therapeutics | 764,224.41 Bn | 764,224.38 Bn | - | - |
| 3 | Legend Biotech | 2,716.00 Bn | 2,715.71 Bn | 242.10 Mn | 7,249.00 |
| 4 | Nanobiotix | 2,248.83 Bn | 2,248.77 Bn | - | - |
| 5 | Akari Therapeutics | 1,951.18 Bn | 1,951.17 Bn | - | - |
| 6 | Vertex Pharmaceuticals | 113.69 Bn | 106.44 Bn | 2.59 Bn | -191.00 |
| 7 | Evaxion A | 64.16 Bn | 64.14 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 63.94 Bn | 55.18 Bn | 3.31 Bn | -33.00 |
| 9 | Alnylam Pharmaceuticals | 40.13 Bn | 37.12 Bn | 959.66 Mn | -480.00 |
| 10 | Cellectis | 20.83 Bn | 20.62 Bn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2023 | 7,759.00 |
| Sep 30, 2023 | -11,022.00 |
| Jun 30, 2023 | 17,003.00 |
| Mar 31, 2023 | -23,111.00 |
| Dec 31, 2022 | 2,805.00 |
| Sep 30, 2022 | -15,957.00 |
| Jun 30, 2022 | 4,557.00 |
| Mar 31, 2022 | 3,344.00 |
| Dec 31, 2021 | -2,630.00 |
| Sep 30, 2021 | -1,503.00 |
| Jun 30, 2021 | -9,410.00 |
| Mar 31, 2021 | -2,223.00 |
| Dec 31, 2020 | -12,382.00 |
| Sep 30, 2020 | -11,726.00 |
| Jun 30, 2020 | -10,415.00 |
| Mar 31, 2020 | -16.00 |
| Dec 31, 2019 | -12,027.00 |
| Sep 30, 2019 | -4,704.00 |
| Jun 30, 2019 | -2,200.00 |
| Mar 31, 2019 | -5,036.00 |
| Dec 31, 2018 | -7,038.00 |
| Sep 30, 2018 | -9,141.00 |
| Jun 30, 2018 | -572.00 |
| Mar 31, 2018 | -452.00 |